Everforth Inc quarterly report, Q2 FY2000

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2000, for On Assignment, Inc. (Note: The input metadata lists "Everforth Inc," but the filing text explicitly identifies the registrant as On Assignment, Inc.). The company operates in two primary segments: Lab Support (laboratory and scientific professionals) and Healthcare Staffing (medical billing and clinical staffing). The company completed a two-for-one stock split in April 2000, and all share data has been retroactively restated.

Key Financial Metrics

Metric Three Months Ended June 30, 2000 Six Months Ended June 30, 2000
Revenues $47,817,000 $92,162,000
Gross Profit $15,654,000 (32.7% margin) $30,100,000 (32.7% margin)
Operating Income $6,619,000 (13.8% margin) $12,875,000 (14.0% margin)
Net Income $4,524,000 $8,730,000
Diluted EPS $0.20 $0.38
Cash and Equivalents (End of Period) $37,919,000
Operating Cash Flow (6 Months) $10,785,000
Total Debt None reported (No long-term debt listed on balance sheet)

Material Changes vs. Prior Period

  • Revenue Growth: Revenues increased 21.8% for the quarter and 24.4% for the six-month period compared to the prior year. This was driven by significant growth in both segments.
  • Segment Performance:
    • Healthcare Staffing: Saw the strongest growth, with revenues up 39.6% (quarter) and 48.0% (six months), driven by a 35.1% increase in temporary employees on assignment.
    • Lab Support: Revenues increased 16.0% (quarter) and 17.3% (six months). Growth was partially offset by a planned decline in the EnviroStaff division's remediation business.
  • Profitability: Net income rose 30.0% for the quarter and 34.0% for the six-month period. Operating expenses as a percentage of revenue decreased slightly due to leveraging centralized support systems.
  • Liquidity: Cash and cash equivalents increased from $24.1 million to $37.9 million. This was fueled by strong operating cash flows ($10.8 million) and significant financing cash inflows ($6.4 million) primarily from stock option exercises.

Outlook, Risks, and Unusual Items

  • Management Commentary: Management attributes growth to strong performance in established markets and new office openings. They believe current cash balances and borrowing ability are sufficient for the next 12 months.
  • Stock Split: A 2-for-1 stock split was effected in April 2000. All historical share and per-share data in the filing have been restated.
  • Corporate Actions: Stockholders approved increasing authorized common stock from 25 million to 75 million shares and increasing the stock option plan reserve from 8 million to 10 million shares.
  • Risks: The company faces risks related to attracting and retaining qualified account managers and temporary employees, managing growth in international markets, and integration of acquired operations. Interest rate and foreign currency risks are deemed not significant.
  • Unusual Items: No material unusual items were reported; results are described as reflecting normal and recurring adjustments.

Investor Verification Checklist

  • Segment Mix: Verify the sustainability of the 48% revenue growth in the Healthcare Staffing segment versus the more modest 17% growth in Lab Support.
  • EnviroStaff Decline: Confirm the timeline and financial impact of the planned decline in the EnviroStaff remediation business.
  • Stock Option Dilution: Review the impact of the approved increase in the stock option plan reserve (to 10 million shares) on future dilution.
  • Workers' Compensation Costs: Monitor the trend in workers' compensation expenses, which increased as a percentage of revenue in the Healthcare segment due to higher premiums.
  • Cash Utilization: Assess how the company intends to deploy its $37.9 million cash balance, given the lack of long-term debt and recent stock repurchase activity.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.